登录/ 注册

Novo Nordisk and Eli Lilly lowered prices of their leading obesity drugs Wegovy and Mounjaro in China to strengthen their positions in a rapidly expanding market facing rising obesity rates

12-30 21:30
利好
利空

热门资讯